ArticleGut2024

TLR8 agonist selgantolimod regulates Kupffer cell differentiation status and impairs HBV entry into hepatocytes via an IL-6-dependent mechanism.

Armando Andres Roca Suarez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.